Is this your brand? Sign in to claim ownership.
Sign in to claim this brandNeurovision Medical Product, Inc.
United States·US-MF-000029865
Last updated May 23, 2026
What Neurovision Medical Product, Inc. makes
Neurovision Medical Product, Inc. manufactures the Neurovision Nerve Locator Monitor (Nerveana), a device used for identifying peripheral nerves during surgical procedures, and EMGView Software, which supports electromyography data analysis and visualization.
The company’s products are classified as Class II devices under FDA regulations and are listed via the 510(k) pathway. The manufacturer is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Neurovision Medical Product, Inc. manufacture?
Neurovision Medical Product, Inc. specializes in devices that assist in surgical and diagnostic procedures. Specifically, they produce the Neurovision Nerve Locator Monitor (Nerveana), which helps surgeons identify peripheral nerves during operations, and EMGView Software, a tool designed for analyzing and visualizing electromyography (EMG) data. These products are developed to enhance precision and safety in clinical settings.
Where is Neurovision Medical Product, Inc. based?
Neurovision Medical Product, Inc. is headquartered in the United States. The company’s location is relevant for regulatory compliance, manufacturing standards, and distribution logistics, particularly for devices intended for the US market or global export.
How are Neurovision Medical Product, Inc.’s devices classified under FDA regulations?
Neurovision Medical Product, Inc.’s devices are classified as Class II under FDA regulations. This classification applies to products that pose moderate risk and require special controls to ensure their safety and effectiveness. Class II devices typically require premarket notification (510(k)) submissions to demonstrate substantial equivalence to a legally marketed predicate device.
Which regulatory registries or databases list Neurovision Medical Product, Inc.’s devices?
Neurovision Medical Product, Inc.’s devices are listed in the FDA’s 510(k) registry. This registry tracks devices that have undergone the 510(k) premarket notification process, ensuring they meet FDA requirements for safety and performance before commercial distribution. The listing confirms the device’s regulatory pathway but does not imply approval—only that it has been reviewed and authorized via the 510(k) process.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- United States
- Address
- 4837, McGrath Steet, Ventura, United States
- Website
- neurovisionmedical.com
- —
- —
- [email protected]
- Phone
- —
- PRRC Contact
- Christine Vergely
- EUDAMED SRN
- US-MF-000029865
- FDA FEI Number
- —
- DUNS Number
- —
Catalogue (102)
Page 1 of 3| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Scorpion | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveäna+® | NONE | FDA UDI | Class II | Active |
| Scorpion | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveäna+® | NONE | FDA UDI | Class II | Active |
| Nerveäna+® | NONE | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Cobra® | N/A | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Cobra | N/A | FDA UDI | Class II | Active |
| Cobra® | N/A | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Unknown |
| Nerveäna+® | NONE | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Dragonfly® | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Cobra | N/A | FDA UDI | Class II | Active |
| Scorpion | N/A | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
| Nerveana® | NONE | FDA UDI | Class II | Active |
| Nerveana | N/A | FDA UDI | Class II | Active |
| Nerveana+® | N/A | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (12)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| May 19, 2025 | Z-2100-2025 | — | open, classified | Product packaging contains the wrong part number and kit contents. |
| Jul 1, 2024 | Z-2719-2024 | — | open, classified | mislabeling; EMG RLN monitoring kit labeling contains the incorrect tube size. |
| Jul 21, 2020 | Z-2903-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2902-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2905-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2906-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2904-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2901-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2908-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2907-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jul 21, 2020 | Z-2900-2020 | — | terminated | The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and render the device not usable. |
| Jan 11, 2010 | Z-0798-2010 | — | terminated | This recall has been initiated due to a conductive glue used to attach the lead wire to electrode, which has been found in a small number of electrodes, to cause a short circuit in one of the channels. This is due to migration of the adhesive from one pad to the other creating an electrical short. Use of one of these defective electrodes could lead to a failure to monitor. Our investigation has c |